Kevin Charles Gorman, Chief Executive Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 10,628 shares at $142.18 ($1.5M) on 2024-02-06, disclosed to the SEC on 2024-02-08.
Scheduled sale ($1.5M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $142.18 | 3,040 | $432K | 29.3% |
| 2 | $142.18 | 3,040 | $432K | 29.3% |
| 3 | $134.15 | 2,274 | $305K | 20.7% |
| 4 | $134.15 | 2,274 | $305K | 20.7% |
| Total | $138.74 avg | 10,628 | $1.5M | 100% |
| Filing → |
| NBIX | SELL | 2025-08-11 | $26.9M | — | Filing → |
| XNCR | SELL | 2025-06-16 | $29K | — | Filing → |
| NBIX | SELL | 2025-05-29 | $2.3M | — | Filing → |